A panel of urinary proteins predicts active lupus nephritis and response to rituximab treatment. (2021)
Attributed to:
MAximizing Sle ThERapeutic PotentiaL by Application of Novel and Stratified approaches (MASTERPLANS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/keaa851
PubMed Identifier: 33313921
Publication URI: http://europepmc.org/abstract/MED/33313921
Type: Journal Article/Review
Volume: 60
Parent Publication: Rheumatology (Oxford, England)
Issue: 8
ISSN: 1462-0324